Predictive role of C-reactive protein in sudden death: a meta-analysis of prospective studies

Ruhua Zhou1, Jingjing Xu2, Jiaochen Luan2

  • 1The College of Nursing, Nanjing Medical University, Nanjing, Jiangsu, China.

Insights

C-reactive protein (CRP) predicts cardiovascular disease risk. This meta-analysis confirms CRP is an independent predictor of sudden death (SD), supporting its use in clinical risk assessment.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Epidemiology

Background:

  • C-reactive protein (CRP) is a known cardiovascular disease risk factor.
  • The association between CRP and sudden death (SD) remains debated.
  • A comprehensive evaluation is needed to clarify CRP's role in SD prediction.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between C-reactive protein (CRP) and sudden death (SD).
  • To determine if CRP is an independent predictor of sudden death.
  • To inform clinical practice regarding CRP measurement for SD risk assessment.

Main Methods:

  • Systematic literature search across multiple databases (PubMed, Web of Science, Embase, etc.).
  • Independent screening and data extraction by two researchers.
  • Meta-analysis of prospective studies using Stata software.

Main Results:

  • Twelve prospective studies with 36,646 patients were included.
  • Higher CRP concentrations were associated with an increased risk of SD (HR, 1.19; 95% CI, 1.09-1.29).
  • Multivariate analysis confirmed CRP as an independent predictor of SD (HR, 1.05; 95% CI, 1.03-1.07).

Conclusions:

  • C-reactive protein (CRP) is confirmed as an independent predictor of sudden death (SD).
  • These findings support the routine measurement of CRP for SD risk stratification in clinical settings.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
247
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
92
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
36
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
182
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
143